Approval · Notice of Compliance 23241 · 2020
NETSPOT: Notice of Compliance 23241
Issued February 21, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23241
- Date
- February 21, 2020
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NETSPOT | Not yet assigned | — |
Medicinal ingredients
- OXODOTREOTIDE 40 MCG per VIAL